aid: bit.bio
name: Bit.bio
description: 'bit.bio is a Cambridge, UK synthetic biology company founded in 2016 by
  stem cell biologist and neurosurgeon Mark Kotter, headquartered at the Babraham Research
  Campus with a second site in San Francisco and a discovery subsidiary (bit.bio discovery
  GmbH) in Vienna. Its proprietary opti-ox cell coding technology uses a dual genomic
  safe harbour approach to deterministically reprogram human induced pluripotent stem
  cells (iPSCs) into defined, consistent human cell types at industrial scale. The
  company sells these as ioCells — ioWild Type Cells, ioDisease Model Cells and CRISPR-Ready
  ioCells covering neurons, microglia, hepatocytes, glial and muscle lineages — plus
  custom iPSC-derived cell development and expert-led CRISPR functional genomics screening
  services for research, drug discovery and cell therapy. Products are sold as physical
  cell vials through a web storefront and a distributor network; bit.bio publishes no
  developer program, public API, or machine-readable API contract.'
url: https://raw.githubusercontent.com/api-evangelist/bit.bio/refs/heads/main/apis.yml
image: https://14527135.fs1.hubspotusercontent-na1.net/hubfs/14527135/Logos/bit.bio/bitbio-logotype-no_tagline-color-positive-RGB.png
x-type: company
x-source: harvest:secondary-market
specificationVersion: '0.23'
created: '2026-08-07'
modified: '2026-08-07'
tags:
- Company
- Synthetic Biology
- Biotechnology
- Life Sciences
- Stem Cells
- Cell Therapy
- Drug Discovery
- Genomics
- CRISPR
- Research Reagents
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/bit.bio-domain-security.yml
- type: LLMsTxt
  url: llms/bit.bio-llms.txt
- type: Website
  url: https://www.bit.bio/
- type: Products
  url: https://www.bit.bio/products
- type: Platform
  url: https://www.bit.bio/platform
- type: Support
  url: https://www.bit.bio/support/technical-support
- type: HelpCenter
  url: https://www.bit.bio/support/technical-faqs
- type: Blog
  url: https://www.bit.bio/blog
- type: News
  url: https://www.bit.bio/news
- type: ContactUs
  url: https://www.bit.bio/contact-us
- type: GitHubOrganization
  url: https://github.com/Bit-Bio
- type: PrivacyPolicy
  url: https://www.bit.bio/privacy
- type: TermsOfService
  url: https://www.bit.bio/hubfs/Documents/Standard-Terms-and-Conditions-for-Sale-of-Goods-and-Services_v04.pdf
- type: LinkedIn
  url: https://www.linkedin.com/company/bitbioltd/
- type: Twitter
  url: https://x.com/bitbio
- type: SecondaryMarket
  url: https://www.hiive.com/securities/bit.bio-stock
x-enrichment:
  date: '2026-08-07'
  status: minimal
  artifacts_added: 3
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: >-
    bit.bio sells cryopreserved human iPSC-derived cell vials and CRISPR screening
    services, ordered through a HubSpot marketing site and a Shopify storefront; there
    is no developer subdomain, no spec at any host root, and the only machine-readable
    endpoints on shop.bit.bio are Shopify platform defaults that an unrelated Shopify
    store returns identically.
  evidence:
  - url: https://www.bit.bio/openapi.json
    status: 404
  - url: https://www.bit.bio/.well-known/api-catalog
    status: 404
  - url: https://www.bit.bio/.well-known/agent-card.json
    status: 404
  - url: https://www.bit.bio/llms.txt
    status: 404
  - url: https://bitbiodiscovery.com/openapi.json
    status: 404
  - url: https://shop.bit.bio/.well-known/openid-configuration
    status: 200
  - url: https://www.allbirds.com/.well-known/openid-configuration
    status: 200
  checked: '2026-08-07'